Bio/Pharma Business

Roche announced the acquisition of Ariosa Diagnostics, a molecular diagnostics testing service provider and maker of the prenatal blood test, Harmony.

The US Federal Trade Commission will require Novartis AG to divest its nicotine replacement therapy patch business to continue the joint venture with GlaxoSmithKline.

Japanese drugmaker Otsuka announced plans to buy CNS-specialist Avanir Pharmaceuticals for $3.5 billion in an all-cash tender offer.

Medtronic announced that it received clearance from both the FTC and European Commission to acquire Covidien for $43 billion.

Despite recent changes in corporate tax law, Ireland remains a valuable and attractive partner in the development and manufacture of biopharmaceuticals.

Merck announced an agreement with NewLink Genetics to acquire exclusive rights to its experimental Ebola vaccine, rVSV-EBOV, for $50 million.

Thermo Fisher Scientific announced a collaboration with Samsung to design, develop, and market new solutions for point-of-care.

An index from the Access to Medicine Foundation ranks GSK as most effective in making products accessible.

GSK and Novartis announced a meeting on Dec. 18, 2014 to discuss the $20 billion asset swap between the two companies.

Spanish-based healthcare company, Grifols, announced that FDA approved the expansion of the plasma fractionation unit at its Clayton, North Carolina facility.

GE Healthcare and Takeda Pharmaceutical Company announced an alliance to develop therapeutic drugs in the field of hepatic fibrosis to treat various liver diseases.

The deal between the two companies will strengthen Perrigo's presence in Europe.

Construction has started on Novo Nordisk's laboratories for diabetes research in Denmark.

AbbVie to pay Shire $1.635 billion break fee for terminating purchase agreement.

Lilly announces the closure of its Guayama, Puerto Rico manufacturing facility amid continued investments at other plants.

AbbVie sends Shire notice that it is reconsidering its offer recommendation.

Vetter's clinical manufacturing services continue to attract new business.

Data analytic strategies can help companies capitalize on personalized medicine.

Partnership is awarded for licensing of low-cost vaccine for the treatment of bacterial meningitis.

GSK is found guilty of offering bribes to doctors and is fined $489 million.

A review of how mergers and acquisitions have shaped the pharmaceutical industry landscape.

After rejecting several bids, Shire has agreed to a merger with AbbVie valued at almost $55 billion.

Mylan set to acquire Abbott's non-US developed markets specialty and branded generics business in an all-stock transaction.

Sandoz will supply antibiotic to developing countries as part of the United Nations' Every Newborn Action Plan.

GSK and Save the Children announce criteria for awards that recognize innovation in healthcare for the world&s poorest children.

PharmSource special report shows demand for cytotoxic injectable drugs could tap existing CMO capacity.

Pharma companies are looking to external sources for innovations that meet future needs.

Novartis' 13th Annual Malaria Expert Panel focused on access to quality anti-malarials across Africa.

PhRMA announced 430 new medicines in development to treat chronic diseases affecting older Americans.